Read More

Renovaro Biosciences And AI Health Company GEDi Cube Sign Definitive Agreement To Combine; GEDi Cube To Become A Wholly-Owned Subsidiary Of Renovaro In Stock-For-Stock Acquisition; GEDi Cube Holders To Own ~50% Of Combined Company

The combined company aims to accelerate precision, personalized medicine for longevity powered by mutually reinforcing AI and biotechnology platforms for early diagnosis, better targeted treatments, and drug

RENB